Trial-level surrogacy is critical before early response endpoints are used to approve new therapies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/JCO.23.01196 | DOI Listing |
Publication Analysis
Top Keywords
early efficacy
4
efficacy points
4
points neoadjuvant
4
neoadjuvant rectal
4
rectal cancer
4
cancer trials
4
trials surrogacy
4
surrogacy revisited
4
revisited trial-level
4
trial-level surrogacy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!